Cambridge, MA, October 19, 2023 (PRNewswire) -- Flagship Pioneering merges Laronde and Senda Biosciences to create Sail Biomedicines. Dr. Guillaume Pfefer, CEO-Partner at Flagship Pioneering, will lead Sail Biomedicines as CEO and board member, focusing on the innovation of fully programmable medicines to advance patient care.
Read full article here.
Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr
Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier therapeutic antibodies, discloses the appointment of Erik van den
Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its acquisition of Relievant Medsystems Inc., the sole provider of the FDA-cl
